<p>在今天發佈的一份報告中，Piper Sandler 的 Jason Bednar 重申了對 Merit Medical Systems 的買入評級，目標價為 96.00 美元。</p>
<h3>在 TipRanks 上享受 55% 的折扣</h3>
<ul>
<li>解鎖對沖基金級別的數據和強大的投資工具，以做出更聰明、更精準的決策</li>
<li>發現表現優異的股票創意，並升級到市場領先者的投資組合，使用智能投資者精選</li>
</ul>
<p>Bednar 關注醫療保健行業，重點關注如 Merit Medical Systems、ICU Medical 和 NovoCure 等股票。根據 TipRanks，Bednar 推薦股票的平均回報為 -5.7%，成功率為 37.06%。</p>
<p>除了 Piper Sandler，Merit Medical Systems 還在 5 月 1 日的報告中獲得了 Barrington 的 Michael Petusky 的買入評級。然而，在同一天，美國銀行證券重申了對 Merit Medical Systems (NASDAQ: MMSI) 的持有評級。</p>

Merit醫療系統

<p>Piper Sandler 分析師 Jason Bednar 對 Merit Medical Systems (MMSI) 維持了買入評級，目標價為 96.00 美元。專注於醫療保健領域的 Bednar，其股票推薦的平均回報率為 -5.7%，成功率為 37.06%。Merit Medical 還獲得了 Barrington 的 Michael Petusky 的買入評級，而美國銀行證券在同一天重申了持有評級</p>

<p>In a report released today, Jason Bednar from Piper Sandler reiterated a Buy rating on Merit Medical Systems, with a price target of $96.00.</p>
<div class="lb-trans"><p>在今天發佈的一份報告中，Piper Sandler 的 Jason Bednar 重申了對 Merit Medical Systems 的買入評級，目標價為 96.00 美元。</p>
</div><h3>Claim 55% Off TipRanks</h3>
<div class="lb-trans"><h3>在 TipRanks 上享受 55% 的折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks</li>
</ul>
<div class="lb-trans"><ul>
<li>解鎖對沖基金級別的數據和強大的投資工具，以做出更聰明、更精準的決策</li>
<li>發現表現優異的股票創意，並升級到市場領先者的投資組合，使用智能投資者精選</li>
</ul>
</div><p>Bednar covers the Healthcare sector, focusing on stocks such as Merit Medical Systems, ICU Medical, and NovoCure. According to TipRanks, Bednar has an average return of -5.7% and a 37.06% success rate on recommended stocks.</p>
<div class="lb-trans"><p>Bednar 關注醫療保健行業，重點關注如 Merit Medical Systems、ICU Medical 和 NovoCure 等股票。根據 TipRanks，Bednar 推薦股票的平均回報為 -5.7%，成功率為 37.06%。</p>
</div><p>In addition to Piper Sandler, Merit Medical Systems also received a Buy from Barrington’s Michael Petusky in a report issued on May 1. However, on the same day, Bank of America Securities reiterated a Hold rating on Merit Medical Systems (NASDAQ: MMSI).</p>
<div class="lb-trans"><p>除了 Piper Sandler，Merit Medical Systems 還在 5 月 1 日的報告中獲得了 Barrington 的 Michael Petusky 的買入評級。然而，在同一天，美國銀行證券重申了對 Merit Medical Systems (NASDAQ: MMSI) 的持有評級。</p>
</div>

Piper Sandler Sticks to Their Buy Rating for Merit Medical Systems (MMSI)

Tip Ranks

Piper Sandler Cos

ICU醫療

NovoCure

美國銀行

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

派傑證券維持對 Merit 醫療系統（MMSI）的買入評級